share_log

歌禮製藥-B：董事會會議通告

ASCLETIS-B: NOTICE OF BOARD MEETING

香港交易所 ·  Feb 23 03:40
Summary by Moomoo AI
歌禮製藥有限公司（「本公司」）將於2024年3月25日（星期一）召開董事會會議，屆時將考慮及批准截至2023年12月31日止年度的業績報告及其發佈。會議同時將討論關於末期股息的派發建議。本公司董事會成員包括執行董事吳勁梓博士及何淨島女士，以及獨立非執行董事魏以楨博士、顧炯先生及華林女士。
歌禮製藥有限公司（「本公司」）將於2024年3月25日（星期一）召開董事會會議，屆時將考慮及批准截至2023年12月31日止年度的業績報告及其發佈。會議同時將討論關於末期股息的派發建議。本公司董事會成員包括執行董事吳勁梓博士及何淨島女士，以及獨立非執行董事魏以楨博士、顧炯先生及華林女士。
Agee Pharmaceuticals Limited (the “Company”) will hold a Board meeting on Monday, 25 March 2024, at which time the results report for the year ended 31 December 2023 and its publication will be considered and approved. The meeting will also discuss the proposed distribution of the final dividend. The members of the Board of Directors include Executive Directors Dr. Wu Jinzi and Ms. Ho Jingshima, as well as Independent Non-Executive Directors Dr. Wei Yizhen, Mr. Gu Jiong and Ms. Wah Lin.
Agee Pharmaceuticals Limited (the “Company”) will hold a Board meeting on Monday, 25 March 2024, at which time the results report for the year ended 31 December 2023 and its publication will be considered and approved. The meeting will also discuss the proposed distribution of the final dividend. The members of the Board of Directors include Executive Directors Dr. Wu Jinzi and Ms. Ho Jingshima, as well as Independent Non-Executive Directors Dr. Wei Yizhen, Mr. Gu Jiong and Ms. Wah Lin.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more